Virtual Reality on Pain and Fear Levels of Children With Primary Immunodeficiency

Not Applicable

Recruiting

• Conditions: Primary Immunodeficiency Diseases (PID)

• Registration Number: NCT07004803
• Lead Sponsor: Dr. Hatice Dönmez

Brief Summary

In this study, it is aimed to investigate the effect of virtual reality and tablet video viewing intervention on pain and fear levels and vital signs of children during peripheral venous catheter placement for intravenous immunoglobulin (IVIG) administration.

Detailed Description

Not available

Study Timeline

• Study Start: 2024-09-15
• Status Verified: 2025-05
• Study First Submitted: 2025-05-27
• Study First Submitted QC: 2025-05-27
• Last Update Submitted: 2025-05-27
• Study First Posted: 2025-06-04
• Last Update Posted: 2025-06-04
• Primary Completion: 2025-09-15
• Study Completion: 2025-10-15

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

• Being between the ages of 4-11
• Being followed up with the diagnosis of Primary Immunodeficiency for at least 6 months
• To accept participation in the study voluntarily
• No additional chronic disease other than primary immunodeficiency

Exclusion Criteria

• Organ failure is present
• Having a mental deficiency
• Having a disability to use VR Glasses
• Children with fever (|>37.5 C0)
• Children with severe dehydration

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Primary Outcome Measures

Name	Time	Method
Children's Fear Scale	5 minutes
Wong-Baker Pain Scale	5 minutes
Children's Emotional Manifestation Scale	5 minutes

Secondary Outcome Measures

Name	Time	Method
Vital Signs	5 minutes	Pulse, oxygen saturation

Trial Locations

Locations (1)

Karamanoglu Mehmetbey University; 🇹🇷 Karaman, Turkey